Ching CA, Villalobos RB, Jiménez VMF

Language: Spanish
References: 16
Page:
PDF size: 293.46 Kb.

ABSTRACT

Leishmaniasis, also known as "papalomoyo", is a chronic parasitic infectious disease caused by a flagellated protozoan of the genus Leishmania, which has more than 20 species. Its presentation and clinical manifestations are variable and depend on the species and the immunological status of the host. The most affected populations are children and young adults under 20 years of age. According to its clinical manifestations, it can be divided into the following presentations: cutaneous, visceral, and mucocutaneous, the first of these being the one with the best prognosis. Among the risk factors for this disease are poverty, malnutrition, migration, inadequate housing conditions, and people who perform rural work, like farmers, agriculturists, or military. The diagnosis can be presumptive or definitive, the clinical characteristics of the disease are key for the presumptive diagnosis and the direct smear is the most used laboratory method, its main objective is to achieve the visualization of amastigotes in the clinical sample. Leishmaniasis is known as "the great imitator", since its clinical manifestations are compatible with multiple pathologies, so differential diagnoses must be made with various diseases. The management of this pathology will vary depending on the type of species and the resistances present.

REFERENCES

1. Abadías-Granado A, Diago PA, Cerro, AM, Palma-Ruiz, Y, Gilaberte, Leishmaniasis cutánea y mucocutánea, Actas Dermo-Sifiliográficas, 2021:112(7):601-618. doi: https://doi.org/10.1016/j.ad.2021.02.008.

2. Gurel MS, Tekin B, Uzun S. Cutaneous leishmaniasis: A great imitator. Clin Dermatol. 2020 Mar-Apr;38(2):140-151. doi: https://doi.org/10.1016/j.clindermatol.2019.10.008

3. Santiago E, Hernández-Bojorge GG, Blass-Alfaro MA, Rickloff MJ, Gómez-Guerrero, RI. Epidemiology of cutaneous and mucocutaneous leishmaniasis in Nicaragua, Parasite Epidemiology and Control, 2020;11. doi: https://doi.org/10.1016/j.parepi.2020.e00192

4. Rojas Madriz B. Leishmaniasis cutánea: una revisión centrada en Costa Rica. Med. leg. Costa Rica [Internet]. 2019 Dec [cited 2022 Jan 22];36(2):82-94. Available from: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152019000200082&lng=en

5. Jaramillo-Antillón O, Espinoza-Aguirre A, Calvo-Fonseca N, Mata-Somarribas C, Wasserman H. La leishmaniosis cutánea en Costa Rica: prevención, diagnóstico y tratamiento. Acta méd. costarric [Internet]. 2018 Sep [cited 2022 Jan 22];60(3):103-114. Available from: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0001-60022018000300103&lng=en

6. Bilgic A, Murrell D, Soner U. Cutaneous leishmaniasis: A neglected disfiguring disease for women, International Journal of Women's Dermatology. 2019;5(3):158-165. doi: https://doi.org/10.1016/j.ijwd.2019.01.002.

7. Alexandra-Jacobs T, Goyenaga-Elizondo I. Leishmaniasis. Crónicas Científicas, 2018;9(9):6-17 Disponible a partir de https://www.cronicascientificas.com/index.php/ediciones/edicion-ix-mayo-agosto-2018/221-leishmaniasis.

8. Sundar S, Singh B. Understanding Leishmania parasites through proteomics and implications for the clinic. Expert Rev Proteomics. 2018 May;15(5):371-390. doi: https://doi.org/10.1080/14789450.2018.1468754

9. Safavi M, Eshaghi H, Hajihassani Z. Visceral Leishmaniasis: Kala-azar. Diagn Cytopathol. 2021 Mar;49(3):446-448. doi: https://doi.org/10.1002/dc.24671

10. Aronson NE, Joya CA. Cutaneous Leishmaniasis: Updates in Diagnosis and Management. Infect Dis Clin North Am. 2019 Mar;33(1):101-117. doi: https://doi.org/10.1016/j.idc.2018.10.004

11. Mirzaei A, Maleki M, Masoumi E, Maspi N. A historical review of the role of cytokines involved in leishmaniasis. Cytokine [Internet]. 2021;145(155297):155297. doi: http://dx.doi.org/10.1016/j.cyto.2020.155297

12. Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018 Sep 15;392(10151):951-970. doi: https://doi.org/10.1016/S0140-6736(18)31204-2

13. Hidalgo Solís MJ, Víquez Redondo KF, Barrantes Valverde SM. Leishmaniasis cutánea. Rev.méd.sinerg. [Internet]. 2021 May [citado 30 de enero de 2022];6(5):e674. doi: https://doi.org/10.31434/rms.v6i5.674

14. Aronson, N. Cutaneous leishmaniasis: Clinical manifestations and diagnosis. UpToDate – Evidence-based Clinical Decision Support | Wolters Kluwer. 2021 Jul. Disponible a partir de: https://www.uptodate.com/contents/cutaneous-leishmaniasis-clinical-manifestations-and-diagnosis?search=Cutaneous%20Leishmaniasis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

15. Bern, C. Visceral leishmaniasis: Clinical manifestations and diagnosis. UpToDate – Evidence-based Clinical Decision Support | Wolters Kluwer. 2021 Ene. Disponible a partir de https://www.uptodate.com/contents/visceral-leishmaniasis-clinical-manifestations-and-diagnosis?search=%20Leishmaniasis&source=search_result&selectedTitle=2~112&usage_type=default&display_rank=2

16. Wikipedia contributors. Leishmaniasis [Internet]. Wikipedia, The Free Encyclopedia. Disponible a partir de: https://es.wikipedia.org/w/index.php? itle=Leishmaniasis&oldid=136862942